GTR Home > Tests > Search results - CN078029[DISCUI]

Apply filters

Showing tests for all 766 conditions

Compare labs

  • Hide states

GTR test search results for CN078029[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 36 tests for 766 conditions in 19 labs

CCoumarin/Warfarin resistance due to CYP2C9 variants

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CWarfarin sensitivity

Lab: Genomic Engenharia Molecular Sao Paulo, Sao Paulo, Brazil
Test targets
Methods
  • T Targeted variant analysis

CCYP2C9 6 variants

Lab: Genetics Laboratory Shodair Children's Hospital Helena, Montana, United States
Test targets
Methods
  • T Targeted variant analysis

CWarfarin Panel

Methods
  • T Targeted variant analysis
Total targets (5)

CCYP2C9

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (5)

CCYP2A6

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (7)

CF9

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (17)

CVKORC1

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (10)

CExome

Lab: DNA CONSULT GENETICA E BIOTECNOLOGIA LTDA. São Carlos, Sao Paulo, Brazil
Test targets
Methods
  • T Targeted variant analysis
Total conditions (59)
Total targets (68)

CPharmacogenetic panel

Lab: bio.logis Center for Human Genetics Frankfurt, Hessen, Germany
Test targets
Methods
  • T Targeted variant analysis
Total conditions (46)
Total targets (29)

CWarfarin response

Lab: bio.logis Center for Human Genetics Frankfurt, Hessen, Germany
Test targets
Methods
  • T Targeted variant analysis

CCytochrome P450 genotyping

Lab: bio.logis Center for Human Genetics Frankfurt, Hessen, Germany
Total conditions (18)
Total targets (8)

CiGene Pharmacogenomics Panel

Lab: ApolloGen, Inc. Irvine, California, United States
Test targets
Methods
  • E Sequence analysis of select exons
Total conditions (14)
Total targets (15)

CSusceptibility to warfarin (CYP2C9 and VKORC1 genes)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • T Targeted variant analysis

CVKORC1 Sequencing

Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Showing 1 to 20 of 36 tests for 766 conditions in 19 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.